As on Thursday, CERo Therapeutics Holdings Inc (NASDAQ: CERO) started slowly as it slid -8.42% to $0.07, before settling in for the price of $0.08 at the close. Taking a more long-term approach, CERO posted a 52-week range of $0.06-$12.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. This publicly-traded company’s shares outstanding now amounts to $147.54 million, simultaneously with a float of $76.76 million. The organization now has a market capitalization sitting at $10.46 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1315, while the 200-day Moving Average is $0.7090.
CERo Therapeutics Holdings Inc (CERO) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. CERo Therapeutics Holdings Inc’s current insider ownership accounts for 48.94%, in contrast to 1.45% institutional ownership. According to the most recent insider trade that took place on Dec 06 ’24, this organization’s 10% Owner sold 1,236,874 shares at the rate of 0.12, making the entire transaction reach 148,425 in total value, affecting insider ownership by 21,383,909. Preceding that transaction, on Dec 10 ’24, Company’s 10% Owner sold 1,570,947 for 0.09, making the whole transaction’s value amount to 141,385. This particular insider is now the holder of 18,962,419 in total.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) Trading Performance Indicators
Let’s observe the current performance indicators for CERo Therapeutics Holdings Inc (CERO). It’s Quick Ratio in the last reported quarter now stands at 0.39. The Stock has managed to achieve an average true range (ATR) of 0.04.
In the same vein, CERO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.44.
Technical Analysis of CERo Therapeutics Holdings Inc (CERO)
Through scrutinizing the latest numbers posted by the [CERo Therapeutics Holdings Inc, CERO], it can be observed that its last 5-days Average volume of 20.92 million was better the volume of 20.45 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 1.68% While, its Average True Range was 0.0370.
Raw Stochastic average of CERo Therapeutics Holdings Inc (CERO) in the period of the previous 100 days is set at 1.56%, which indicates a major rise in contrast to 0.80% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 275.56% that was higher than 253.61% volatility it exhibited in the past 100-days period.
